Radovich Peter — SEC Form 4 filings
SEC reporting owner CIK 1650131. 19 Form 4 filings on record with FilingPulse; latest filed 2026-06-08.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2024-01-09 to 2026-06-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 14 legs across 13 filings — 64,082 shares, $3,931,025 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 29.
- Largest priced transaction: sale of 16,515 shares @ $91.98 ($1,519,015) in Mirum Pharmaceuticals, Inc., filed 2026-03-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | PRESIDENT AND COO | 18 | — | 14 legs · 64,082 sh · $3,931,025 | 24 |
| Rain Oncology Inc. (RAIN) | Director | 1 | — | — | 5 |
Form 4 filings — Radovich Peter
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-08 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 16,988 @ $19.19 · Option exercise (M): 16,988 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 7,220 · Option exercise (M): 23,000 · Sale (S): 16,515 @ $91.98 · Option exercise (M): 7,220 (derivative) @ $0 · Option exercise (M): 23,000 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 5,912 @ $15.87 · Option exercise (M): 5,912 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 2,631 @ $103.30 | EDGAR |
| 2026-01-30 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 25,120 (derivative) @ $0 · Grant/award (A): 16,280 (derivative) @ $0 · Grant/award (A): 34,500 (derivative) @ $0 | EDGAR |
| 2026-01-27 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 5,750 · Sale (S): 3,143 @ $96.19 · Option exercise (M): 5,750 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 4,167 · Sale (S): 2,382 @ $93.33 · Option exercise (M): 4,167 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 14,440 · Sale (S): 7,879 @ $44.21 · Option exercise (M): 14,440 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 13,681 @ $45.57 · Sale (S): 1,169 @ $45.74 | EDGAR |
| 2025-02-04 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 2,627 @ $48.22 | EDGAR |
| 2025-01-27 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 5,750 · Sale (S): 3,177 @ $47.92 · Option exercise (M): 5,750 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 12,500 (derivative) @ $0 · Grant/award (A): 21,660 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 1,998 @ $42.82 | EDGAR |
| 2024-03-25 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 4,303 @ $25.80 | EDGAR |
| 2024-03-18 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 1,379 @ $20.62 | EDGAR |
| 2024-02-05 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 1,790 @ $26.19 | EDGAR |
| 2024-01-26 | 4 | Rain Oncology Inc. (RAIN) | Code (U): 8,796 · Disposition to issuer (D): 13,890 (derivative) · Disposition to issuer (D): 42,596 (derivative) · Disposition to issuer (D): 35,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) | EDGAR |
| 2024-01-25 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 17,250 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 1,408 @ $28.03 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1650131 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →